论文部分内容阅读
高脂血症是脑梗塞发病机理中主要因素之一,降低血脂是预防、治疗脑梗塞方法之一。我们于1997年7月~1998年3月间对血脂康治疗脑梗塞伴高脂血症的临床疗效及毒副作用进行了临床观察,现总结如下: 一、资料和方法 1.病例选择:本组60例高脂血症患者均为本院住院及门诊病人。脑梗塞诊断按第二次全国脑血管病会议制定的脑梗塞诊断标准,并经头部CT或MRI确诊。血脂异常诊断标准:TC≥
Hyperlipidemia is one of the main factors in the pathogenesis of cerebral infarction, and lowering blood lipids is one of the ways to prevent and treat cerebral infarction. We in July 1997 ~ March 1998 Xuezhikang treatment of cerebral infarction with hyperlipidemia clinical efficacy and side effects of clinical observation, are summarized as follows: I. Materials and Methods 1. Case Selection: This group 60 cases of patients with hyperlipidemia are hospitalized hospital and outpatients. Diagnosis of cerebral infarction Diagnostic criteria for cerebral infarction developed by the Second National Cerebrovascular Disease Conference and confirmed by CT or MRI of the head. Dyslipidemia diagnostic criteria: TC ≥